Research ArticleOriginal Research

Prediabetes Knowledge, Attitudes, and Practices at an Academic Family Medicine Practice

James W. Keck, Alisha R. Thomas, Laura Hieronymus and Karen L. Roper
The Journal of the American Board of Family Medicine July 2019, 32 (4) 505-512; DOI: https://doi.org/10.3122/jabfm.2019.04.180375

References

  1. 1.↵
    Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374:1677–86.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    National diabetes statistics report: Estimates of diabetes and its burden in the United States, 2014. Atlanta, GA: Centers for Disease Control and Prevention; 2017.
  3. 3.↵
    1. Ali MK,
    2. Bullard KM,
    3. Gregg EW,
    4. et al
    . A cascade of care for diabetes in the United States: Visualizing the gaps. Ann Intern Med 2014;161:681–9.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Kiefer MM,
    2. Silverman JB,
    3. Young BA,
    4. et al
    . National patterns in diabetes screening: Data from the National Health and Nutrition Examination Survey (NHANES) 2005–2012. J Gen Intern Med 2015;30:612–8.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Geiss LS,
    2. James C,
    3. Gregg EW,
    4. et al
    . Diabetes risk reduction behaviors among U.S. adults with prediabetes. Am J Prev Med 2010;38:403–9.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Centers for Disease Control and Prevention. Awareness of prediabetes—United States, 2005–2010. MMWR Morb Mortal Wkly Rep 2013;62:209–12.
    OpenUrlPubMed
  7. 7.↵
    1. Hemmingsen B,
    2. Gimenez-Perez G,
    3. Mauricio D,
    4. et al
    . Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev 2017;2017(12).
  8. 8.↵
    1. Knowler WC,
    2. Barrett-Connor E,
    3. Fowler SE,
    4. et al
    . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Tuomilehto J,
    2. Lindström J,
    3. Eriksson JG,
    4. et al
    . Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343–50.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Pronk NP,
    2. Remington PL
    . Combined diet and physical activity promotion programs for prevention of diabetes: Community preventive services task force recommendation statement. Ann Intern Med 2015;163:465–8.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Schmittdiel JA,
    2. Adams SR,
    3. Segal J,
    4. et al
    . Novel use and utility of integrated electronic health records to assess rates of prediabetes recognition and treatment: brief report from an integrated electronic health records pilot study. Diabetes Care 2014;37:565–8.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Mensa-Wilmot Y,
    2. Bowen SA,
    3. Rutledge S,
    4. et al
    . Early results of States' efforts to support, scale, and sustain the National Diabetes Prevention Program. Prev Chronic Dis 2017;14:E130.
    OpenUrl
  13. 13.↵
    1. Mainous AG 3rd.,
    2. Tanner RJ,
    3. Scuderi CB,
    4. et al
    . Prediabetes screening and treatment in diabetes prevention: The impact of physician attitudes. J Am Board Fam Med 2016;29:663–71.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Yudkin JS,
    2. Montori VM
    . The epidemic of pre-diabetes: The medicine and the politics. BMJ 2014;349:g4485.
    OpenUrlFREE Full Text
  15. 15.↵
    1. Tseng E,
    2. Greer RC,
    3. O'Rourke P,
    4. et al
    . Survey of primary care providers' knowledge of screening for, diagnosing and managing prediabetes. J Gen Intern Med 2017;32:1172–8.
    OpenUrl
  16. 16.↵
    1. Vojta D,
    2. Koehler TB,
    3. Longjohn M,
    4. et al
    . A coordinated national model for diabetes prevention: Linking health systems to an evidence-based community program. Am J Prev Med 2013;44(4 Suppl 4):S301–S306.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Chambers EC,
    2. Wylie-Rosett J,
    3. Blank AE,
    4. et al
    . Increasing referrals to a YMCA-based diabetes prevention program: Effects of electronic referral system modification and provider education in federally qualified health centers. Prev Chronic Dis 2015;12:E189.
    OpenUrl
  18. 18.↵
    1. Cloney TA,
    2. Galer-Unti RA,
    3. Barkley WM
    . Provider practices in prediabetes intervention and diabetes prevention: application of evidence-based research in the medical office setting. J Prim Care Community Health 2011;2:187–91.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Gallivan J,
    2. Greenberg R,
    3. Brown C
    . The National Diabetes Education Program evaluation framework: How to design an evaluation of a multifaceted public health education program. Prev Chronic Dis 2008;5(4):A134.
    OpenUrlPubMed
  20. 20.↵
    1. Nhim K,
    2. Khan T,
    3. Gruss SM,
    4. et al
    . Primary care providers' prediabetes screening, testing, and referral behaviors. Am J Prev Med 2018;55:e39–e47.
    OpenUrl
  21. 21.↵
    1. Gopalan A,
    2. Lorincz IS,
    3. Wirtalla C,
    4. Marcus SC,
    5. Long JA
    . Awareness of prediabetes and engagement in diabetes risk–reducing behaviors. Am J Prev Med 2015;49:512–9.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Mehta S,
    2. Mocarski M,
    3. Wisniewski T,
    4. et al
    . Primary care physicians' utilization of type 2 diabetes screening guidelines and referrals to behavioral interventions: A survey-linked retrospective study. BMJ Open Diabetes Res Care 2017;5(1).
  23. 23.↵
    1. Hafez D,
    2. Nelson DB,
    3. Martin EG,
    4. Cohen AJ,
    5. Northway R,
    6. Kullgren JT
    . Understanding type 2 diabetes mellitus screening practices among primary care physicians: a qualitative chart-stimulated recall study. BMC Fam Pract 2017;18:50.
    OpenUrl
  24. 24.↵
    1. Fearn-Smith JD,
    2. Evans PH,
    3. Harding G,
    4. et al
    . Attitudes of GPs to the diagnosis and management of impaired glucose tolerance: The practitioners' attitudes to hyperglycaemia (PAtH) questionnaire. Prim Care Diabetes 2007;1:35–41.
    OpenUrl
  25. 25.↵
    1. Helmink JHM,
    2. Kremers SPJ,
    3. van Boekel LC,
    4. et al
    . Factors determining the motivation of primary health care professionals to implement and continue the “Beweegkuur” lifestyle intervention programme. J Eval Clin Pract 2012;18:682–8.
    OpenUrlCrossRefPubMed
  26. 26.↵
    U.S. Preventive Services Task Force. Final recommendation statement: Abnormal blood glucose and type 2 diabetes mellitus: Screening. November 2, 2018. Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/screening-for-abnormal-blood-glucose-and-type-2-diabetes.
  27. 27.↵
    American Academy of Family Physicians. Clinical preventive service recommendation: Abnormal blood glucose and type 2 diabetes mellitus, adults. 2015. Available from: https://www.aafp.org/patient-care/clinical-recommendations/all/diabetes-screening.html.
  28. 28.↵
    1. Sacks DB,
    2. Arnold M,
    3. Bakris GL,
    4. et al
    . Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011;34:e61–e99.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    American Diabetes Association. Standards of medical care in diabetes-2017 abridged for primary care providers. Clin Diabetes 2017 Jan;35:5–26.
    OpenUrlFREE Full Text
  30. 30.↵
    American Medical Association. Prevent diabetes STAT. Available from: https://assets.ama-assn.org/sub/prevent-diabetes-stat/. Published 2018. Accessed October 23, 2018.
  31. 31.↵
    1. Craven MA,
    2. Kates N,
    3. Raso P
    . Assessment of family physicians' knowledge of social and community services. Can Fam Physician 1990;36:443–7.
    OpenUrlPubMed
  32. 32.↵
    1. Marshall C,
    2. Adams S,
    3. Dyer W,
    4. et al
    . Opportunities to reduce diabetes risk in women of reproductive age: Assessment and treatment of prediabetes within a large integrated delivery system. Womens Health Issues 2017;27:666–72.
    OpenUrl
  33. 33.↵
    1. Mainous AG 3rd.,
    2. Tanner RJ,
    3. Baker R
    . Prediabetes diagnosis and treatment in primary care. J Am Board Fam Med 2016;29:283–5.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Moin T,
    2. Li J,
    3. Duru OK,
    4. et al
    . Metformin prescription for insured adults with prediabetes from 2010 to 2012: A retrospective cohort study. Ann Intern Med 2015;162:542–8.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Wu J,
    2. Ward E,
    3. Threatt T,
    4. Lu ZK
    . Metformin prescribing in low-income and insured patients with prediabetes. J Am Pharm Assoc 2017;57:483–7.
    OpenUrl
  36. 36.↵
    1. Schnell O,
    2. Crocker JB,
    3. Weng J
    . Impact of HbA1c testing at point of care on diabetes management. J Diabetes Sci Technol 2017;11:611–7.
    OpenUrl
  37. 37.↵
    1. Whitley HP,
    2. Hanson C,
    3. Parton JM
    . Systematic diabetes screening using point-of-care HbA1c testing facilitates identification of prediabetes. Ann Fam Med 2017;15:162–4.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords